HONGBO (HK) INTERNATIONAL TRADE CO., LIMITED – Trademark Portfolio

Entity Type: 16

HONGBO (HK) INTERNATIONAL TRADE CO., LIMITED holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 34 (Smokers Articles) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include HARYGATE. The owner is based in HONG KONG.

FLAT/RM 06 BLK A 23/F HOOVER INDUSTRIAL

BUILDING NO 26-38 KWAI CHEONE ROAD KWAI CHUNG NT

HONG KONG 999077 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SUPGLORY
SUPGLORY
Abandoned 2019
HARYGATE
HARYGATE
Registered 2018

Trademark Classifications

HONGBO (HK) INTERNATIONAL TRADE CO., LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

34
Smokers Articles (2 filings)

Tobacco; smokers articles; matches

Frequently Asked Questions

How many trademarks does HONGBO (HK) INTERNATIONAL TRADE CO., LIMITED have?

HONGBO (HK) INTERNATIONAL TRADE CO., LIMITED has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does HONGBO (HK) INTERNATIONAL TRADE CO., LIMITED file in?

HONGBO (HK) INTERNATIONAL TRADE CO., LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 34 (Smokers Articles). Class 34 covers tobacco; smokers articles; matches.

What are HONGBO (HK) INTERNATIONAL TRADE CO., LIMITED's most well-known trademarks?

HONGBO (HK) INTERNATIONAL TRADE CO., LIMITED's registered trademark portfolio includes well-known marks such as HARYGATE. These are among 1 currently registered trademark in the portfolio.

What is HONGBO (HK) INTERNATIONAL TRADE CO., LIMITED's trademark registration success rate?

HONGBO (HK) INTERNATIONAL TRADE CO., LIMITED has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.